STOCK TITAN
  1. Home
  2. Financials
  3. PVCT
  4. EPS (Diluted)

PROVECTUS BIOPHARMS (PVCT) EPS by Year

PVCT

PROVECTUS BIOPHARMS lost $0.01 per diluted share in fiscal year 2025. That is unchanged from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $0.00 per diluted share. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters PROVECTUS BIOPHARMS has filed alongside them.

FY2025 annual
EPS (Diluted) -$0.01
YoY 0.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PVCT EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
EPS (Diluted)$0.00-$0.010.0%-$0.010.0%-$0.010.0%-$0.01N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

PVCT EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
EPS (Diluted)$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More PROVECTUS BIOPHARMS financials

Frequently Asked Questions

What was PROVECTUS BIOPHARMS's diluted earnings per share in fiscal year 2025?

PROVECTUS BIOPHARMS lost $0.01 per diluted share in fiscal year 2025.

How fast is PROVECTUS BIOPHARMS's diluted earnings per share growing?

PROVECTUS BIOPHARMS (PVCT) diluted earnings per share was essentially unchanged year over year, at -$0.01 in fiscal year 2025 against -$0.01 the year before.

What is PROVECTUS BIOPHARMS's diluted earnings per share over the last twelve months?

PROVECTUS BIOPHARMS (PVCT) reported $0.00 per diluted share over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

PROVECTUS BIOPHARMS (PVCT) reported $0.00 in diluted earnings per share in Q2 2026.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what PROVECTUS BIOPHARMS (PVCT) reported on that line in every period on record.